Tirzepatide beats semaglutide for weight loss in Canada, with clinical trials showing up to 22.5% body weight reduction versus 14.9% for semaglutide at the highest doses. Both are GLP-1 receptor agonists, but tirzepatide also activates GIP receptors, giving it a dual mechanism that drives greater appetite suppression and fat loss. This article compares tirzepatide vs semaglutide weight loss results, costs, side effects, and availability across Canada so you can decide which peptide fits your goals.

How Tirzepatide and Semaglutide Work for Weight Loss

Semaglutide is a GLP-1 receptor agonist sold as Ozempic and Wegovy in Canada. It mimics the hormone GLP-1, which slows stomach emptying, reduces appetite, and improves insulin sensitivity. Tirzepatide, sold as Mounjaro and Zepbound, is a dual GIP and GLP-1 receptor agonist. GIP enhances insulin secretion and may further reduce food intake. This dual action is why tirzepatide often produces more weight loss than semaglutide at comparable doses.

Both peptides require weekly subcutaneous injections. They are not interchangeable, and dosing schedules differ. In Canada, semaglutide for weight loss starts at 0.25 mg weekly and increases to 2.4 mg. Tirzepatide starts at 2.5 mg and can reach 15 mg weekly. The higher efficacy of tirzepatide comes with a higher price tag, which we cover below.

Clinical Trial Results: Tirzepatide vs Semaglutide Weight Loss

The SURMOUNT-1 trial tested tirzepatide in 2,539 adults without diabetes. At 72 weeks, participants lost an average of 15% body weight on 5 mg, 19.5% on 10 mg, and 20.9% on 15 mg, versus 3.1% for placebo. The STEP 1 trial for semaglutide 2.4 mg showed 14.9% average weight loss at 68 weeks. A head-to-head trial, SURMOUNT-5, directly compared tirzepatide 10 mg or 15 mg to semaglutide 2.4 mg. Tirzepatide led to 20.2% weight loss versus 13.7% for semaglutide at 72 weeks.

For Canadians, these numbers translate to real differences. A 100 kg person might lose 20 kg on tirzepatide versus 14 kg on semaglutide. However, individual results vary. Some people respond better to semaglutide, especially if they experience fewer side effects. Cost and insurance coverage also play a role.

Cost Comparison in Canada: Tirzepatide vs Semaglutide

In Canada, semaglutide for weight loss costs roughly $250 to $400 per month without insurance, depending on the pharmacy and dose. Tirzepatide is more expensive, ranging from $350 to $600 per month. Both are available by prescription, but provincial drug plans rarely cover weight loss medications. Private insurance may cover semaglutide for type 2 diabetes but often denies coverage for obesity alone. Tirzepatide is approved for type 2 diabetes in Canada, and Zepbound for weight loss was approved in late 2024.

If you are looking to buy tirzepatide in Quebec, you can check current prices at local pharmacies or online peptide suppliers. Some Canadians turn to research peptide vendors for lower prices, but this carries legal and safety risks. Always verify the source and ensure the product is tested for purity.

Side Effects: Which GLP-1 Is Better Tolerated?

Both tirzepatide and semaglutide cause similar gastrointestinal side effects: nausea, vomiting, diarrhea, and constipation. In clinical trials, nausea occurred in about 30% of tirzepatide users and 44% of semaglutide users. Tirzepatide may cause slightly less nausea at lower doses, but the difference is not dramatic. Both drugs carry a risk of gallbladder disease, pancreatitis, and thyroid C-cell tumors in rodents. They are not recommended for people with a personal or family history of medullary thyroid cancer or MEN 2.

For Canadians, the choice often comes down to side effect tolerance. Some people find semaglutide's nausea too strong and switch to tirzepatide, while others do the opposite. Starting at a low dose and increasing slowly reduces side effects. Your doctor can help you manage this.

Dosing and Administration in Canada

Semaglutide for weight loss in Canada follows a standard titration. You start at 0.25 mg weekly for 4 weeks, then increase every 4 weeks to 0.5 mg, 1 mg, 1.7 mg, and finally 2.4 mg. Tirzepatide starts at 2.5 mg weekly and increases by 2.5 mg every 4 weeks until you reach 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg. Most people see significant weight loss at 10 mg or higher.

Both peptides come in pre-filled pens. Semaglutide pens deliver a fixed dose per injection. Tirzepatide pens are also fixed dose. You inject subcutaneously in the abdomen, thigh, or upper arm. Rotate injection sites to avoid lipohypertrophy.

Which GLP-1 Is Better for Weight Loss in Canada?

For maximum weight loss, tirzepatide is the better choice. The dual GIP/GLP-1 mechanism leads to greater average weight reduction. However, semaglutide is cheaper and has a longer track record in Canada. If cost is a major factor, semaglutide may be more accessible. If you want the highest efficacy and can afford it, tirzepatide is the winner.

Some Canadians combine GLP-1 peptides with other research peptides for enhanced fat loss. For example, AOD-9604 is a peptide fragment that may stimulate lipolysis. You can read about AOD-9604 dosage for fat loss in Quebec to learn more. However, always consult a healthcare provider before stacking peptides.

Availability and Prescription Requirements

Both tirzepatide and semaglutide require a prescription from a Canadian physician or nurse practitioner. You cannot buy them over the counter. Telehealth services like Felix, Livewell, and Maple can prescribe weight loss medications after an online consultation. In-person clinics also prescribe them, but wait times may be longer.

Pharmacies across Canada stock both drugs, but supply can fluctuate. Semaglutide has faced shortages in the past. Tirzepatide supply has been more stable since its launch. If you are in Quebec, you can check tirzepatide 10 mg price in Quebec pharmacies for current costs. For semaglutide dosing details, see our semaglutide dosage guide for Canada.

Real-World Results: What Canadians Report

Online forums and Reddit threads show mixed experiences. Many Canadians report losing 10 to 15 percent of body weight on semaglutide within 6 months. Tirzepatide users often report faster and larger losses, sometimes 15 to 20 percent in the same period. Side effects are the main reason people stop either drug. Nausea and fatigue are common in the first month.

Some users combine GLP-1s with peptides like BPC-157 for gut health or TB-500 for recovery. While not directly for weight loss, these may help with side effects. You can learn about buying BPC-157 5mg in Canada if interested. But focus on the GLP-1 first.

Safety and Long-Term Considerations

Both tirzepatide and semaglutide are relatively safe for most people, but long-term data is still limited. Semaglutide has been on the market longer, so more safety data exists. Tirzepatide's dual action raises theoretical concerns about GIP receptor activation, but no serious safety signals have emerged in trials. Both drugs can cause weight regain if stopped. Most people need to stay on them long-term to maintain weight loss.

For Canadians with type 2 diabetes, both drugs improve glycemic control. Tirzepatide may lower A1c more than semaglutide. If you have diabetes and obesity, tirzepatide might be the better option. Discuss with your endocrinologist.

Final Verdict: Tirzepatide vs Semaglutide for Weight Loss in Canada

Tirzepatide is the stronger weight loss peptide, but semaglutide is more affordable and widely available. Your choice depends on budget, side effect tolerance, and how much weight you need to lose. For most Canadians, semaglutide is a solid first option. If you plateau or need more aggressive loss, tirzepatide is worth the extra cost.

Always consult a healthcare provider before starting any GLP-1 peptide. They can help you navigate insurance, dosing, and monitoring. For more peptide information, explore our guides on AOD-9604 and other research peptides.